Although miR-181 miRNA family was report with clear effects on CD4+T cell development and homeostasis, at least partly, similar to the functions as IL-22 shown35; our results demonstrate that miR-181 could be employed as a prognostic biomarker for CM development, as well as a predictor for CM outcome. Here, IL22 is linked to cutaneous mastocytosis.